The Vanguard Growth ETF holds large positions in tech giants like Nvidia, with a healthy splash of diversification.

Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...

FNDA offers diversified small-cap exposure, attractive valuation versus indices, and lags VUG’s tech-heavy performance. Learn ...

As of November 27, CRISPR Therapeutics AG (NASDAQ:CRSP) has a moderately positive opinion, with 60% analysts covering it having a Buy or equivalent rating. With a consensus 1-year median price target ...

Given these factors, my favorite index ETF to outperform in 2026 is the Vanguard Mega Cap Growth ETF as it's one of the most ...

Investors looking to win in AI have turned to chip giant Nvidia, propelling the stock to a double-digit gain this year. This other tech stock also is on track to lead in the AI market -- and it’s a ...

Most Wall Street analysts love Nvidia's growth story. Nvidia's valuation is the only concern. In general, Wall Street loves Nvidia stock. The consensus price prediction over the next 12 months is ...

Most Wall Street analysts love Nvidia's growth story. Nvidia's valuation is the only concern. 10 stocks we like better than Nvidia › Nvidia (NASDAQ: NVDA) is now the most valuable company in the world ...